560 related articles for article (PubMed ID: 20637731)
1. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
2. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
3. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat.
Baluchnejadmojarad T; Roghani M; Khastehkhodaie Z
Phytother Res; 2010 Aug; 24(8):1120-5. PubMed ID: 19960427
[TBL] [Abstract][Full Text] [Related]
5. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
Han LP; Yu DM; Xie Y
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
[TBL] [Abstract][Full Text] [Related]
6. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
[TBL] [Abstract][Full Text] [Related]
7. [The role of oxidative stress in experimental diabetic neuropathy].
Wang L; Zheng KJ; Dong DY; Sun Y; Wang YM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):108-11. PubMed ID: 21141571
[TBL] [Abstract][Full Text] [Related]
8. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system.
Catanzaro O; Capponi JA; Michieli J; Labal E; Di Martino I; Sirois P
Peptides; 2013 Jun; 44():100-4. PubMed ID: 23528517
[TBL] [Abstract][Full Text] [Related]
10. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
11. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy.
Bianchi R; Cervellini I; Porretta-Serapiglia C; Oggioni N; Burkey B; Ghezzi P; Cavaletti G; Lauria G
J Pharmacol Exp Ther; 2012 Jan; 340(1):64-72. PubMed ID: 21984837
[TBL] [Abstract][Full Text] [Related]
13. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
14. Effects of cytidine 5'-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice.
Kamei J; Ohsawa M; Miyata S; Endo K; Hayakawa H
Eur J Pharmacol; 2008 Nov; 598(1-3):32-6. PubMed ID: 18834878
[TBL] [Abstract][Full Text] [Related]
15. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
Hoybergs YM; Meert TF
Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver.
Yilmaz HR; Uz E; Yucel N; Altuntas I; Ozcelik N
J Biochem Mol Toxicol; 2004; 18(4):234-8. PubMed ID: 15452882
[TBL] [Abstract][Full Text] [Related]
17. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
Kamboj SS; Vasishta RK; Sandhir R
J Neurochem; 2010 Jan; 112(1):77-91. PubMed ID: 19840221
[TBL] [Abstract][Full Text] [Related]
19. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats.
Jin HY; Lee KA; Song SK; Liu WJ; Choi JH; Song CH; Baek HS; Park TS
Eur J Pharmacol; 2012 Jan; 674(2-3):217-26. PubMed ID: 21641343
[TBL] [Abstract][Full Text] [Related]
20. Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats.
Wang CF; Li DQ; Xue HY; Hu B
Brain Res; 2010 Jan; 1307():158-65. PubMed ID: 19852947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
